Japan Re-approves Thalidomide For Cancer Treatment
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Ministry of Health, Labor and Welfare has approved re-listing thalidomide, which Japan banned in 1962 for causing serious human deformations, to be marketed by Fujimoto Pharmaceutical, officials of the ministry's Pharmaceutical and Food Bureau and the Insurance Bureau confirmed Oct. 7